Live Quote · NASDAQFATEHealthcare· Biotechnology

Fate Therapeutics, Inc.

$0.92▼ 9.01%($-0.09)
MKT CAP $107.12MNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
49/100
▌ Weak
47
Valuation
35
Profitability
55
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FATE research report →

Analyst Price Target
$5.63+512.6% vs. today

Range $3.5 – $8

Analyst RatingBuy
16 Buy13 Hold2 Sell

Price Chart

-8.10% · this period
$3.11$2.01$0.92Nov 20May 26Nov 20
52-Week Range1% of range
Low
$0.90
Current
$0.92
High
$3.23